Literature DB >> 27845190

Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen.

Hisayuki Yokoyama1, Junya Kanda2, Shigeo Fuji3, Sung-Won Kim3, Takahiro Fukuda3, Yuho Najima4, Hitoshi Ohno5, Naoyuki Uchida6, Yasunori Ueda7, Tetsuya Eto8, Koji Iwato9, Hikaru Kobayashi10, Yukiyasu Ozawa11, Tadakazu Kondo12, Tatsuo Ichinohe13, Yoshiko Atsuta14, Yoshinobu Kanda15.   

Abstract

The impact of HLA mismatch in hematopoietic stem cell transplantation with reduced-intensity conditioning (RIC) has not been fully examined. We analyzed a total of 1130 cases to examine the effects of HLA allele mismatch in unrelated bone marrow transplantation (BMT) with RIC in the Japan Marrow Donor Program registry cohort. Compared with HLA 8/8-allele match (n = 720, 8/8 match), both 1 (n = 295, 7/8 match) and 2 allele mismatches (n = 115, 6/8 match) were associated with significant reduction of overall survival (OS) (hazard ratio [HR],  1.34; P = .0024 and HR, 1.33; P = .035 for 7/8 and 6/8 match, respectively). The incidence of grades 2 to 4 acute graft-versus-host disease (aGVHD) increased with increasing number of mismatched alleles (HR, 1.36 and HR, 2.08 for 7/8 and 6/8 match, respectively). Nonrelapse mortality showed a similar tendency to aGVHD (HR, 1.35 for 7/8 and HR, 1.63 for 6/8). One-allele mismatches at the HLA-A or -B and HLA-C loci were significantly associated with inferior OS compared with 8/8 match (HR, 1.64 for A or B mismatch and HR, 1.41 for C mismatch), whereas HLA-DRB1 allele mismatch was not (HR, 1.16; P = .30). However, the effect of HLA-A or -B and -C mismatch on OS was not observed in those who received RIC BMT since 2010, in contrast to recipients before 2010. These results suggested that in unrelated RIC BMT, 1-allele mismatch is associated with poorer outcome, and the impact of HLA mismatch may differ depending on the HLA locus, although these HLA mismatch effects may be different in recent cases.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HLA mismatch; Reduced-intensity conditioning; Unrelated bone marrow transplantation

Mesh:

Substances:

Year:  2016        PMID: 27845190     DOI: 10.1016/j.bbmt.2016.11.009

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  3 in total

1.  Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.

Authors:  Brian Kornblit; Barry E Storer; Niels S Andersen; Michael B Maris; Thomas R Chauncey; Effie W Petersdorf; Ann E Woolfrey; Mary E D Flowers; Rainer Storb; David G Maloney; Brenda M Sandmaier
Journal:  Blood       Date:  2020-09-24       Impact factor: 22.113

2.  HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity.

Authors:  Michael A Spinner; Marcelo Fernández-Viña; Lisa E Creary; Olivia Quinn; Linda Elder; Sally Arai; Laura J Johnston; Everett H Meyer; David B Miklos; Lori S Muffly; Robert S Negrin; Judith A Shizuru; Wen-Kai Weng; Ginna G Laport; Samuel Strober; Robert Lowsky; Andrew R Rezvani
Journal:  Blood Adv       Date:  2017-07-25

3.  Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients.

Authors:  Takahiko Nakane; Hiroshi Okamura; Yumi Tagaito; Shiro Koh; Takuro Yoshimura; Yosuke Makuuchi; Satoru Nanno; Mika Nakamae; Asao Hirose; Yasuhiro Nakashima; Hideo Koh; Masayuki Hino; Hirohisa Nakamae
Journal:  Int J Hematol       Date:  2019-09-27       Impact factor: 2.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.